2m 2m 2m 2m 2m 2m 2m
Cerus (CERS)
NASDAQ
$2.21+$0.06 (+2.56%)
Price as of Aug 03, 2026 1:01 PM EDT- $430.8MMarket Cap
- 69.29%1-Year Change
- Medical DevicesIndustry
Cerus (CERS)
$2.21+$0.06 (+2.56%)
CERS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.15 | ||
Change | -$0.74 (-25.61%) | ||
Open | $2.43 | ||
High | $2.46 | ||
Low | $2.06 | ||
Previous Close | $2.89 | ||
Volume | 8,325,591 | ||
30-Day Average Volume | 2,594,879 | ||
1-Week Change | -26.62% | ||
1-Month Change | -26.37% | ||
1-Year Change | 69.29% | ||
3-Year Change | -29.97% | ||
5-Year Change | -57.34% | ||
Fundamentals | |||
Shares Outstanding | 200.4M | ||
Total Assets | $205.2M | ||
Market Cap | $430.8M | ||
Enterprise Value | $477.7M | ||
Period: QTR TTM FY | |||
Revenue | $57.4M | ||
Net Income | -$2.9M | ||
Free Cash Flow | -$3.5M | ||
EBIT | -$2.8M | ||
EBITDA | -$2.4M | ||
Net Working Capital | $71.5M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -200 | ||
Enterprise Value/Revenue | 8 | ||
P/B | 6 | ||
P/E | -215 | ||
PEG | N/A | ||
Price/Free Cash Flow | -122 | ||
Price/Operating Cash Flow | -162 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue